Design and optimize cardiometabolic trials by addressing complexity, endpoints, recruitment, and regulatory requirements.

ERMProtect is pleased to announce the expansion of its cybersecurity services with the addition of Georgios Mortakis, former CIO and CISO of Norwegian Cruise Line Holdings, who joins the firm as a ...

Minimal residual disease (MRD) is becoming one of the most important response biomarkers in oncology development. Once viewed primarily as a hematologic endpoint, MRD is now influencing broader ...

Adimab, LLC, the global leader in the discovery and engineering of fully human monoclonal and multispecific antibodies, congratulates GSK plc for recently receiving approvals by the European ...

Keith B. Alexander joins Einride's Board of Directors to support defense-grade security, cyber resilience, and scaling of Einride's offer within the defense space. The appointment marks the next step ...

Copay programs now directly influence access and manufacturer financial performance amid high deductibles, ...

University of Tennessee researchers James Ostrowski and Rebekah Herrman are developing quantum-computing tools to tackle multi-stage stochastic decision problems in fields like energy, logistics, and ...

Android 17 Beta 4 is now available for Pixel 6 and newer devices.

As lentiviral vector (LVV) programs advance toward larger clinical trials and commercialization, manufacturing platforms and ...

China’s birdlike drones mark a new era in flight—merging biology and technology to create quieter, more efficient machines ...

New agreement supports clinical supply of a dual PI3K and mTOR inhibitor for actinic keratosis, enabling process optimization ...

Patients are traveling abroad for longevity and aesthetic treatments—seeking advanced care, better access, and lower costs in ...